Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model

Surgery Today

Volumn 40, Issue 9, 2010, Pages 851-857

  Imaizumi, Takuya ^a   Aoyagi, Keishiro ^a   Miyagi, Motoshi ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bevacizumab; Gastric cancer; Peritoneal metastasis model; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; ASCITES FLUID LEVEL; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; METASTASIS INHIBITION; MITOSIS; MOUSE; NONHUMAN; PERITONEUM METASTASIS; STOMACH CANCER; SURVIVAL RATE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; ASCITES; CELL LINE, TUMOR; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOTIC INDEX; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956936929     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4154-y     Document Type: Article

References (27)

1. S. Sakuramoto M. Sasako T. Yamaguchi T. Kinoshita M. Fujii A. Nashimoto, et al. 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 10.1056/NEJMoa072252 1:CAS:528:DC%2BD2sXht1Kit7bI 17978289 (Pubitemid 350044801)
2. M. Ikeguchi T. Miyake T. Matsunaga M. Yamamoto Y. Fukumoto Y. Yamada, et al. 2009 Recent results of therapy for scirrhous gastric cancer Surg Today 39 290 294 10.1007/s00595-008-3860-1 1:CAS:528:DC%2BD1MXjsFyltrc%3D 19319634
3. Y. Yonemura Y. Endou T. Yamaguchi 1996 Mechanisms of the formation of the peritoneal dissemination in gastric cancer Int J Oncol 8 795 802 (Pubitemid 26109946)
4. Yonemura Y. Peritoneal dissemination. Tokyo: Health Publishers; 1996.
5. L.A. Liotta 1986 Tumor invasion and metastases-role of the extracellular matrix Cancer Res 46 1 7 10.1016/S0065-230X(08)60034-2 1:CAS:528: DyaL28Xjt1Ckug%3D%3D 2998604
6. B.K. Zebrowski W. Liu K. Ramirez Y. Akagi G.B. Mills L.M. Ellis 1999 Markedly elevated levels of vascular endothelial growth factor in malignant ascites Ann Surg Oncol 6 373 378 10.1007/s10434-999-0373-0 1:STN:280: DyaK1Mzgs1GhtA%3D%3D 10379858 (Pubitemid 29260800)
7. H.F. Dvorak L.F. Brown M. Detmar A.M. Dvorak 1995 Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 50 1209 1239
8. D. Belotti P. Paganoni L. Manenti A. Garofalo S. Marchini G. Taraboletti, et al. 2003 Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation Cancer Res 63 5224 5229 1:CAS:528: DC%2BD3sXntlektLw%3D 14500349
9. K. Aoyagi K. Kouhuji S. Yano M. Miyagi T. Imaizumi J. Takeda, et al. 2005 VEGF significance in peritoneal recurrence from gastric cancer Gastric Cancer 8 155 163 10.1007/s10120-005-0329-4 1:CAS:528:DC%2BD2MXntVeht7s%3D 16086118 (Pubitemid 41176094)
10. M. Miyagi K. Aoyagi S. Kato K. Shirouzu 2007 The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer Int J Clin Oncol 12 17 24 10.1007/s10147-006-0616-z 1:CAS:528:DC%2BD2sXjvVKlt74%3D 17380436 (Pubitemid 46472548)
11. D.R. Senger S.J. Galli A.M. Dvorak C.A. Perruzzi Y. Harvey H.F. Dvorak 1983 Tumor cells secret a vascular permeability factor that promotes accumulation of ascites fluid Science 219 983 985 10.1126/science.6823562 1:STN:280:DyaL3s7hvF2mtw%3D%3D 6823562
12. N. Ferrara W.J. Henzel 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem Biophys Res Commun 161 851 858 10.1016/0006-291X(89)92678-8 1:CAS:528: DyaL1MXkslWhtbY%3D 2735925 (Pubitemid 19162712)
13. M.S. Pepper N. Ferrara L. Orci R. Montesano 1991 Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells Biochem Biophys Res Commun 181 902 906 10.1016/0006-291X(91)91276-I 1:CAS:528:DyaK38XhtVSjt7w%3D 1755866
14. E.N. Uenomori N. Ferrara E.A. Bauer E.P. Amento 1992 Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells J Cell Physiol 153 357 362
15. R.M. Shaheen D.W. Davis W. Liu B.K. Zebrowski M.R. Wilson C.D. Bucana, et al. 1999 Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis Cancer Res 59 5412 5416 1:CAS:528:DyaK1MXnt1Gjtbg%3D 10554007
16. H.P. Gerber A. McMurtrey J. Kowalski M. Yan B.A. Keyt V. Dixit, et al. 1998 Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway: requirement for Klk-1/FDR activation J Biol Chem 273 30336 30343 10.1074/jbc.273.46.30336 1:CAS:528:DyaK1cXnsVyrtb0%3D 9804796 (Pubitemid 28545503)
17. P. Lissoni F. Malugani A. Bonfanti R. Bucovec S. Secondino F. Brivio, et al. 2001 Abnormally enhanced blood concentrations of vascular growth factors (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1 J Biol Regul Homeost Agents 15 140 144 1:CAS:528:DC%2BD3MXovFSgtb4%3D 11501971
18. L.M. Ellis D.J. Hicklin 2008 Pathways mediating resistance to vascular endothelial growth factor-targeted therapy Clin Cancer Res 14 6371 6375 10.1158/1078-0432.CCR-07-5287 1:CAS:528:DC%2BD1cXht1KgtbrJ 18927275
19. J. Yoneda H. Kuniyasu M.A. Crispens J.E. Price C.D. Bucana I.J. Fidler 1998 Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice J Natl Cancer Inst 90 447 454 10.1093/jnci/90.6.447 1:CAS:528:DyaK1cXitlejtbg%3D 9521169
20. Y. Kondo S. Arii A. Mori M. Furutani T. Chiba M. Imamura 2000 Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into Lo Vo human colon cancer cell line Clin Cancer Res 6 622 630 1:CAS:528:DC%2BD3cXhs1akt78%3D 10690548 (Pubitemid 30111488)
21. A. Mori S. Arii M. Furutani M. Mizumoto S. Uchida H. Furuyama, et al. 2000 Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes Gene Ther 7 1027 1033 10.1038/sj.gt.3301202 1:CAS:528: DC%2BD3cXkt1amsbY%3D 10871751
22. J.A. Nagy E.M. Masse K.T. Herzberg M.S. Meyers K.T. Yeo T.K. Yeo, et al. 1995 Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation Cancer Res 55 360 368 1:CAS:528:DyaK2MXjtFyjsbs%3D 7812969
23. A. Kraft K. Weindel A. Ochs C. Marth J. Zmija P. Schumacher, et al. 1999 Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease Cancer 85 178 187 10.1002/(SICI)1097- 0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7 1:STN:280: DyaK1M7hvV2ltg%3D%3D 9921991 (Pubitemid 29031373)
24. S. Mesiano N. Ferrara R.B. Jaffe 1998 Role of vascular growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization Am J Pathol 153 1249 1256 1:CAS:528:DyaK1cXmvFGmt7Y%3D 9777956
25. H. Wildiers G. Guetens G. De Boeck E. Verbeken B. Landuyt W. Landuyt, et al. 2003 Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11 Br J Cancer 88 1979 1986 10.1038/sj.bjc.6601005 1:CAS:528:DC%2BD3sXksVKjtbk%3D 12799646 (Pubitemid 36829677)
26. N. Ferrara K.J. Hillan H.P. Gerber W. Novotny 2004 Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 391 400 10.1038/nrd1381 1:CAS:528:DC%2BD2cXktlCrt78%3D 15136787
27. R.K. Jain R.T. Tong L.L. Munn 2007 Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model Cancer Res 67 2729 2735 10.1158/0008-5472.CAN-06-4102 1:CAS:528:DC%2BD2sXivV2nsLw%3D 17363594 (Pubitemid 46548961)